Kambiz Akbari Noghabi | Biological Sciences | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Kambiz Akbari Noghabi | Biological Sciences | Best Researcher Award

Prof. Dr. Kambiz Akbari Noghabi, National Institute of Genetic Engineering and Biotechnology (NIGEB), Iran.

Dr. Kambiz Akbari Noghabi is a distinguished microbiologist and biotechnologist whose academic journey began with a Ph.D. in Applied Microbiology-Biotechnology from Gyeongsang National University, South Korea. His pioneering research on cold-induced biopolymers by Pseudomonas fluorescens has been a cornerstone in microbial environmental applications. With a strong foundation in environmental and industrial biotechnology, his research explores the molecular biology of microorganisms, focusing on their potential to address pressing ecological issues.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Dr. Kambiz Akbari Noghabi embarked on his academic journey with a deep passion for the microscopic world of microorganisms. He pursued his Ph.D. in Applied Microbiology-Biotechnology at Gyeongsang National University (GNSU), South Korea, from 2003 to 2006. Demonstrating academic excellence, he graduated with an average grade of “A.” His doctoral thesis, entitled “Production of a novel cold-induced biopolymer by Pseudomonas fluorescens BM07; its structural characterization & environmental applications,” not only explored an innovative microbial product but also reflected his dedication to eco-conscious scientific discovery. Recognizing his outstanding capabilities, he was awarded a prestigious BK21 (Brain Korea 21 Program) scholarship—one of South Korea’s most competitive supports for international scholars.

🧫 Research Focus and Scientific Curiosity

Driven by a profound interest in microbial science, Dr. Akbari Noghabi’s research is centered on Environmental and Industrial Biotechnology, with an emphasis on the cellular and molecular biology of microorganisms. His interdisciplinary work spans microbial natural products, environmental microbiology, and bio-nanotechnology. He has continuously explored innovative applications of microbes in solving environmental challenges, demonstrating an exceptional blend of academic rigor and creativity. His research on cold-induced biopolymers remains an example of how basic microbiological insight can inspire sustainable technological advancement.

🔬 Professional Endeavors and Multidisciplinary Integration

Throughout his career, Dr. Akbari Noghabi has collaborated across various disciplines within biological sciences. His scientific curiosity led him to initiate and participate in multidisciplinary projects, which often integrate aspects of biotechnology, molecular biology, and environmental engineering. Whether exploring the behavior of bacteria at the genetic level or developing new methods for environmental cleanup using microbial technologies, he has consistently contributed to the expanding interface between science and society.

🏅 Accolades and Recognition

Recognition has been a natural outcome of Dr. Akbari Noghabi’s relentless pursuit of scientific excellence. His academic merit earned him the highly respected BK21 scholarship during his doctoral studies, acknowledging him as an emerging leader in biotechnology. Beyond this, his work continues to be acknowledged globally through invitations to contribute as a referee for some of the most prestigious scientific journals, affirming the value and credibility of his scientific judgment.

📚 Refereeing Excellence and Scholarly Impact

As a reviewer for an extensive list of world-renowned journals—including Enzyme and Microbial Technology, Bioresource Technology, Scientific Reports, PLoS ONE, and Biotechnology & Bioengineering—Dr. Akbari Noghabi has helped shape the direction of microbial biotechnology research. His engagement with journals from Elsevier, Wiley, Springer, and others reflects not only his subject expertise but also the trust placed in him by the global scientific community to uphold rigorous academic standards and promote impactful research.

🌍 Impact on Science and Society

Dr. Akbari Noghabi’s work carries significant implications for both science and society. His research contributes directly to solving real-world problems, especially in the realm of environmental sustainability. By leveraging microbial capabilities for biopolymer production and environmental remediation, he has provided pathways for cleaner technologies and greener industry practices. His contributions echo in environmental policy discussions, technological innovation, and the academic development of future scientists.

🔮 Legacy and Future Contributions

Looking forward, Dr. Kambiz Akbari Noghabi remains poised to inspire the next generation of biotechnologists and microbiologists. His career is a testament to the power of interdisciplinary science, international collaboration, and persistent curiosity. With a legacy already grounded in scientific integrity and environmental advocacy, his ongoing efforts will undoubtedly continue to shape the future of microbial biotechnology and its applications across sectors.

Publication

  • Title: An efficient biosurfactant-producing bacterium Pseudomonas aeruginosa MR01, isolated from oil excavation areas in south of Iran
    Authors: TB Lotfabad, M Shourian, R Roostaazad, AR Najafabadi, MR Adelzadeh, …
    Year: 2009

 

  • Title: Biosurfactant-producing bacterium, Pseudomonas aeruginosa MA01 isolated from spoiled apples: physicochemical and structural characteristics of isolated biosurfactant
    Authors: H Abbasi, MM Hamedi, TB Lotfabad, HS Zahiri, H Sharafi, F Masoomi, …
    Year: 2012

 

  • Title: Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals
    Authors: F Shahcheraghi, M Abbasalipour, MM Feizabadi, GH Ebrahimipour, …
    Year: 2011

 

  • Title: Structural characterization of a rhamnolipid-type biosurfactant produced by Pseudomonas aeruginosa MR01: enhancement of di-rhamnolipid proportion using gamma irradiation
    Authors: TB Lotfabad, H Abassi, R Ahmadkhaniha, R Roostaazad, F Masoomi, …
    Year: 2010

 

  • Title: Efficient phenol degradation by a newly characterized Pseudomonas sp. SA01 isolated from pharmaceutical wastewaters
    Authors: M Shourian, KA Noghabi, HS Zahiri, T Bagheri, R Karbalaei, M Mollaei, …
    Year: 2009

 

  • Title: Characterization of a chitinase with antifungal activity from a native Serratia marcescens B4A
    Authors: M Zarei, S Aminzadeh, H Zolgharnein, A Safahieh, M Daliri, KA Noghabi, …
    Year: 2011

 

  • Title: A bio-inspired strategy for the synthesis of zinc oxide nanoparticles (ZnO NPs) using the cell extract of cyanobacterium Nostoc sp. EA03: from biological function to toxicity
    Authors: M Ebadi, MR Zolfaghari, SS Aghaei, M Zargar, M Shafiei, HS Zahiri, …
    Year: 2019

 

  • Title: Halophiles and their vast potential in biofuel production
    Authors: MA Amoozegar, A Safarpour, KA Noghabi, T Bakhtiary, A Ventosa
    Year: 2019

 

✅ Conclusion

Dr. Kambiz Akbari Noghabi’s work stands at the intersection of innovation, environmental responsibility, and scientific excellence. Through his research and professional service, he has carved out a lasting legacy in microbial biotechnology. His commitment to advancing the frontiers of science while addressing environmental challenges ensures that his contributions will continue to resonate across generations of researchers and practitioners. Looking ahead, his career promises even greater strides in the pursuit of sustainable, microbe-driven solutions to global problems.

Lucas Lopes | Medicina | Best Researcher Award

Published on by Neuroscientists

Mr. Lucas Lopes | Medicina | Best Researcher Award

Mr. Lucas Lopes, Universidade de São Paulo, Faculdade de Medicina de Bauru,  Brazil.

Lucas Casagrande Passoni Lopes has made significant strides in medical research, academic publishing, and global scientific collaboration. His expertise in pediatric medicine, endocrinology, and healthcare disparities has been widely recognized through his editorial leadership, peer-review contributions, and multilingual engagements. His published works address critical healthcare issues, further cementing his influence in the medical community.

Profile

Orcid

🎓 Early Academic Pursuits

Lucas Casagrande Passoni Lopes embarked on his academic journey with an unwavering passion for medicine, enrolling in the prestigious Faculdade de Medicina de Bauru at the Universidade de São Paulo, Brazil. His commitment to excellence and keen interest in pediatric and clinical research set the foundation for his future endeavors. Throughout his academic years, he demonstrated exceptional dedication, immersing himself in scientific studies and medical advancements, laying the groundwork for a promising career in healthcare and medical research.

👩‍🎓 Professional Endeavors

Beyond his medical studies, Lucas took on significant roles in the academic publishing landscape. As the In-Chief Editor of Advances in Modern Paediatrics Journal, he has played a pivotal role in shaping pediatric research dissemination. His editorial contributions extend to renowned medical journals, including Journal of Anaesthesia and Global Open Share Publishing, Clinics of Neurology, Annals of Pediatrics and Neonatal Care, and the European Journal of Cancer. Through his editorial expertise, he has facilitated the publication of groundbreaking research, furthering advancements in multiple medical disciplines.

🔬 Contributions and Research Focus

Lucas has established himself as a prolific researcher, focusing on pediatric medicine, endocrinology, and public health concerns. His notable studies include an in-depth analysis of treatments for dysmenorrhea in adolescents, published in Contemporânea – Revista de Ética e Filosofia Política, and a groundbreaking study on the underreporting of diabetes mellitus as a cause of death over 40 years in Bauru, published in Archives of Endocrinology and Metabolism. His work sheds light on critical gaps in healthcare reporting and patient management, making substantial contributions to medical literature and clinical practice.

🏆 Accolades and Recognition

Lucas’ dedication to medical research has earned him esteemed recognition within the scientific community. As an invited reviewer for numerous high-impact journals, including Current Pediatric Reviews, World Journal of Clinical Cases, International Journal of Clinical and Experimental Medical Sciences, World Journal of Gastroenterology, and Frontiers in Medicine, he has been entrusted with evaluating and shaping contemporary medical research. His expertise is widely acknowledged, with his insights influencing the peer-review process across various fields of medicine.

📚 Impact and Influence

Lucas’ influence extends far beyond his research and editorial roles. His multilingual proficiency in Portuguese, English, French, Italian, Spanish, and German allows him to engage with diverse international scientific communities, fostering cross-border collaborations. His involvement in global medical discourse ensures that cutting-edge research reaches a broader audience, ultimately contributing to the improvement of healthcare systems worldwide. His mentorship and editorial leadership have guided emerging researchers, amplifying the impact of his contributions to medical academia.

🌟 Legacy and Future Contributions

With a strong foundation in medical research and editorial expertise, Lucas continues to shape the future of pediatric and clinical medicine. His ongoing commitment to identifying healthcare disparities, advancing treatment methodologies, and supporting evidence-based medical practices positions him as a key figure in modern medical research. As he forges ahead, his contributions promise to enhance patient care, influence policy reforms, and inspire future generations of medical professionals. His legacy in scientific inquiry and knowledge dissemination will undoubtedly leave a lasting mark on the field of medicine.

 

publication

  • Title: Association between exanthematous diseases and earlier age at Type 1 diabetes diagnosis
    Authors: Lucas C.P. Lopes, Lenita Zajdenverg, Rodrigo L.M. Martins, Gabriel Araujo Medeiros, Marina D. Louro, João V.M. Lanzarin, Carlos A. Negrato
    Year: 2025

 

  • Title: Mortality trends from all causes and diabetes mellitus according to sex between 1998 and 2021
    Authors: Carlos Antonio Negrato, Gabriel Araújo Medeiros, Giordano Bruno Duarte de Souza, Lucas Casagrande Passoni Lopes
    Year: 2024

 

  • Title: Relationship between early age at menarche, older age at menopause and subtypes of breast cancer: a scoping review
    Authors: Lucas Casagrande Passoni Lopes, Gabriel Araújo Medeiros, Igor José Nogueira Gualberto, Thales Baptista Gut, Rafael Vasconcelos Silva Ferrazini, Carlos Antonio Negrato
    Year: 2024

 

  • Title: Association between perinatal and obstetric factors and early age at diagnosis of type 1 diabetes mellitus: a cohort study
    Authors: Carlos A. Negrato, Rodrigo L. de M. Martins, Marina D. Louro, Gabriel A. Medeiros, João V.M. Lanzarin, Lenita Zajdenverg, Lucas C.P. Lopes
    Year: 2024

 

  • Title: Underreporting of diabetes mellitus as the cause of death in Bauru, State of São Paulo, Brazil over 40 years: a documental study
    Authors: Lucas Casagrande Passoni Lopes, Gabriel Araújo Medeiros, Mauro Wieczorek, Marina dos Santos de Carvalho Pinto, Carlos Antonio Negrato
    Year: 2024

 

🎉 Conclusion

As a dedicated researcher, editor, and medical professional, Lucas Passoni continues to push the boundaries of medical knowledge and patient care. His contributions have not only enriched scientific literature but have also fostered meaningful discussions on global healthcare improvements. With his unwavering commitment to excellence, Lucas is poised to leave a lasting legacy in the field of medicine, inspiring future generations of researchers and practitioners alike.

 

 

Magdalena Budzyń | Immunology | Women Researcher Award

Published on by Neuroscientists

Assist. Prof. Dr. Magdalena Budzyń | Immunology | Women Researcher Award

Assist. Prof. Dr. Magdalena Budzyń, Poznan University of Medical Sciences, Poland.

Dr. Magdalena Budzyń is an accomplished researcher and educator specializing in cardiovascular diseases and laboratory diagnostics. With a strong academic foundation from Poznan University of Medical Sciences, she earned her Ph.D. in Medical Sciences and later achieved the prestigious habilitated doctor qualification. Her research focuses on endothelial damage markers and their role in cardiovascular conditions, contributing valuable insights into disease mechanisms. As an Assistant Professor, she has been dedicated to both scientific discovery and mentoring future medical professionals.

Profile

Orcid

Early Academic Pursuits 🎓

Born on April 4, 1982, Dr. Magdalena Budzyń embarked on her academic journey with a passion for medical sciences. Her educational path began at Poznan University of Medical Sciences, where she pursued an in-depth study of laboratory diagnostics. She completed her Ph.D. in Medical Sciences between 2009 and 2013, focusing on the intricate balance between leukocyte elastase and its inhibitor alpha1-antitrypsin in chronic venous insufficiency. With an insatiable curiosity for cardiovascular research, she further advanced her academic credentials by earning a habilitated doctor degree in 2022, exploring circulating markers of endothelial damage and their clinical implications in cardiovascular diseases.

Professional Endeavors 🏅

Dr. Budzyń’s professional career has been a testament to her dedication to medical research and education. She has been an integral part of Poznan University of Medical Sciences since 2007, serving as an Assistant Professor. Prior to that, she gained valuable experience at Poznan Veterinary Institute as a Technical Assistant, where she honed her laboratory and analytical skills. Her expertise in laboratory medicine and medical chemistry has made her a respected academic in her field, contributing significantly to both research and teaching.

Contributions and Research Focus 🔬

Her research primarily revolves around cardiovascular diseases, with a particular emphasis on endothelial damage markers. By investigating the role of these biomarkers, she has provided critical insights into the pathophysiology of vascular disorders. Her work has contributed to the understanding of chronic venous insufficiency and how leukocyte elastase imbalance impacts disease progression. Additionally, her studies in laboratory diagnostics have strengthened the role of clinical biomarkers in predicting and managing cardiovascular conditions.

Accolades and Recognition 🏆

Dr. Budzyń’s academic excellence has been recognized through her habilitated doctor qualification, a prestigious milestone in her career. Her contributions to medical sciences have been acknowledged within the scientific community, as she continues to shape the field of cardiovascular research. Her role as an educator and mentor further amplifies her influence, guiding students toward meaningful research endeavors in laboratory medicine and diagnostics.

Impact and Influence 🌍

Beyond academia, Dr. Budzyń’s research has a profound impact on the medical field, particularly in improving diagnostic tools for cardiovascular diseases. Her findings contribute to enhanced patient care by identifying key biomarkers that aid in early disease detection and treatment planning. She actively collaborates with researchers and medical professionals, ensuring that her work bridges the gap between scientific discovery and clinical application.

publication

  • Significance of the monocyte CCR2-CCL2 axis in triple-negative breast cancer
    Authors: Magdalena Budzyń, Agata Kubicka, Elżbieta Kaja, Witold Kycler, Joanna Załuska-Kusz, Jacek J. Brzeziński, Marcelina Sperling, Alicja Bukowska, Joanna Grupińska
    Year: 2025

 

  • Nutritional Behaviors, Vitamin Supplementation and Physical Activity among Polish Adults during the COVID-19 Pandemic
    Authors: Bogna Gryszczyńska, Magdalena Budzyń, Joanna Grupińska, Magdalena Paulina Kasprzak, Agnieszka Gryszczyńska
    Year: 2022

 

  • Beneficial Effects of Oral Nutritional Supplements on Body Composition and Biochemical Parameters in Women with Breast Cancer Undergoing Postoperative Chemotherapy: A Propensity Score Matching Analysis
    Authors: Joanna Grupińska, Magdalena Budzyń, Kalina Maćkowiak, Jacek Jakub Brzeziński, Witold Kycler, Ewa Leporowska, Bogna Gryszczyńska, Magdalena Paulina Kasprzak, Maria Iskra, Dorota Formanowicz
    Year: 2021

 

  • Association between clinicopathological features of breast cancer with adipocytokine levels and oxidative stress markers before and after chemotherapy
    Authors: Magdalena Budzyń
    Year: 2021

 

  • Changes in the Nrf2/Keap1 Ratio and PON1 Concentration in Plasma of Patients Undergoing the Left Main Coronary Artery Stenting
    Authors: Magdalena Budzyń
    Year: 2020

 

  • Selected Atherosclerosis-Related Diseases May Differentially Affect the Relationship between Plasma Advanced Glycation End Products, Receptor sRAGE, and Uric Acid
    Authors: Bogna Gryszczyńska, Magdalena Budzyń, Dorota Formanowicz, Maria Wanic-Kossowska, Piotr Formanowicz, Wacław Majewski, Maria Iskra, Magdalena P. Kasprzak
    Year: 2020

 

  • Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension
    Authors: Magdalena Budzyń
    Year: 2019

 

  • The Potential Role of Circulating Endothelial Cells and Endothelial Progenitor Cells in the Prediction of Left Ventricular Hypertrophy in Hypertensive Patients
    Authors: Magdalena Budzyń
    Year: 2019

 

  • Advanced Oxidation Protein Products and Carbonylated Proteins Levels in Endovascular and Open Repair of an Abdominal Aortic Aneurysm: The Effect of Pre-, Intra-, and Postoperative Treatment
    Authors: Bogna Gryszczyńska, Magdalena Budzyń, Dorota Formanowicz, Piotr Formanowicz, Zbigniew Krasiński, Natalia Majewska, Maria Iskra, Magdalena P. Kasprzak
    Year: 2019

 

Conclusion

Dr. Budzyń’s contributions to medical sciences extend beyond academia, influencing the fields of laboratory diagnostics and cardiovascular research. Her work has significantly improved the understanding of endothelial dysfunction and biomarker-based diagnostics, paving the way for better clinical applications. With her ongoing dedication to research and education, she continues to inspire the next generation of scientists while striving to make impactful advancements in medical science.

Zewen Cheng | Clinical Medicine | Young Scientist Award

Published on by Neuroscientists

Dr. Zewen Cheng | Clinical Medicine | Young Scientist Award

Dr. Zewen Cheng, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine,  China.

Zewen Cheng’s career is a testament to his dedication to thoracic surgery, combining expertise in both Western and Traditional Chinese medicine. His academic excellence, professional experience, and research contributions highlight his unwavering commitment to advancing patient care. As a skilled surgeon and educator, he continues to make a significant impact in the medical community. Moving forward, his focus on innovation and mentorship will ensure that his contributions leave a lasting mark on the field of thoracic surgery, inspiring future generations of medical professionals.

Profile

Scopus

 

🎓 Early Academic Pursuits

Zewen Cheng embarked on his medical journey with a passion for thoracic surgery, earning a Master of Medicine in Thoracic Surgery from Soochow University in Suzhou, China. Graduating in 2019, he dedicated himself to mastering the complexities of thoracic diseases, developing a strong foundation in both clinical and surgical practices. His academic years were marked by rigorous training and an unwavering commitment to patient care, setting the stage for his future contributions to the medical field.

🏥 Professional Endeavors

After completing his degree, Zewen Cheng undertook a comprehensive three-year residency at The First Affiliated Hospital of Soochow University. From July 2019 to June 2022, he refined his expertise in thoracic surgery, gaining invaluable hands-on experience in clinical diagnostics, patient management, and surgical procedures. His tenure in the residency program enabled him to work closely with senior specialists, tackling complex cases and honing his skills. In September 2022, he advanced to the role of Attending Physician at Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, where he seamlessly integrates Western and Traditional Chinese medical treatments to provide holistic patient care.

🔬 Contributions and Research Focus

Zewen Cheng is deeply invested in the evolving landscape of thoracic surgery. His research interests span innovative surgical techniques, minimally invasive procedures, and the integration of Traditional Chinese Medicine (TCM) in thoracic disease management. With proficiency in data analysis software such as R and SPSS, he actively contributes to medical research, utilizing statistical methodologies to enhance clinical decision-making. His work emphasizes the importance of interdisciplinary approaches in improving patient outcomes and advancing the field of thoracic surgery.

🏆 Accolades and Recognition

Throughout his medical career, Zewen Cheng has been recognized for his dedication and expertise in thoracic surgery. Successfully completing the standardized residency training at The First Affiliated Hospital of Soochow University, he demonstrated exceptional skill and commitment to surgical excellence. His fluency in Medical English (CET-6) has enabled him to collaborate effectively with international medical professionals, further expanding his impact within the global medical community.

💪 Impact and Influence

As an Attending Physician, Zewen Cheng plays a crucial role in supervising and training junior doctors, fostering the next generation of thoracic surgeons. His ability to blend traditional and modern medical practices ensures that patients receive comprehensive treatment tailored to their specific needs. His contributions extend beyond direct patient care, as he actively participates in multidisciplinary teams, shaping the future of thoracic surgery through collaborative innovation and knowledge sharing.

🌟 Legacy and Future Contributions

With a strong foundation in both clinical practice and research, Zewen Cheng aspires to push the boundaries of thoracic surgery through continuous learning and innovation. His commitment to integrating Traditional Chinese Medicine with contemporary surgical techniques presents new avenues for patient care and treatment efficacy. Looking ahead, he envisions contributing to groundbreaking research, refining surgical methodologies, and mentoring future medical professionals, leaving a lasting legacy in the field of thoracic surgery.

 

Publication

Title: Exploring the Causal Relationship Between Frailty and Chronic Obstructive Pulmonary Disease: Insights From Bidirectional Mendelian Randomization and Mediation Analysis
Authors: Zewen Cheng, Jian Wu, Chun Xu, Xiaokun Yan
Year: 2025

 

🏆 Conclusion

Zewen Cheng is a strong candidate for the Young Scientist Award, given his clinical expertise, innovative approach to medicine, and commitment to training future surgeons. Strengthening his research impact and expanding international collaborations would further solidify his position as a leading young scientist in thoracic surgery.

 

 

Basanta Kumar das | Immunology | Best Researcher Award

Published on by Neuroscientists

Dr. Basanta Kumar das | Immunology | Best Researcher Award

Dr. Basanta Kumar das, Central Inland Fisheries Research Institute,  India.

Dr. Basanta Kumar Das is a distinguished fisheries scientist and Director of ICAR-Central Inland Fisheries Research Institute (CIFRI), Kolkata. Born in Odisha in 1966, he pursued his Ph.D. from Orissa University of Agriculture and Technology and later completed his postdoctoral research at FRS Marine Lab, Scotland. Throughout his career, he has significantly contributed to disease management in open-water fish ecosystems, aquaculture health management, molecular epidemiology of fish diseases, and antiviral gene expression studies in carps. He has also developed medicines for ornamental fish diseases, immunostimulants, and bioactive compounds from algae and plant derivatives.

Profile

Google Scholar

 

Early Academic Pursuits 🎓

Born on March 20, 1966, in Athilabaj, District Balasore, Odisha, Dr. Basanta Kumar Das embarked on an academic journey that laid the foundation for his remarkable contributions to fisheries science. He pursued his education at the Orissa University of Agriculture and Technology, earning his Ph.D. in 1998. His relentless thirst for knowledge led him to a prestigious post-doctoral fellowship at the FRS Marine Lab in Aberdeen, Scotland, UK (2006–2007), where he deepened his expertise in aquatic health and disease management. His early academic pursuits cemented his position as a leading authority in fisheries research, blending traditional knowledge with modern scientific approaches.

Professional Endeavors and Leadership 🌊

Dr. Das has dedicated his career to revolutionizing inland fisheries and aquaculture. Currently serving as the Director of ICAR-Central Inland Fisheries Research Institute (CIFRI), Kolkata, he has spearheaded numerous initiatives to enhance aquatic resource management. Beyond his directorial role, he serves as the President of the Inland Fisheries Society of India, President of the Professional Fisheries Graduates Forum, and President of the Orissa Fisheries College Alumni Association. These leadership positions reflect his unwavering commitment to fostering scientific communities and strengthening professional networks in fisheries and aquatic sciences.

Contributions and Research Focus 🔬

Dr. Das’s research has been instrumental in addressing critical challenges in fisheries science. His expertise spans diverse areas, including disease management in open-water fish ecosystems, health management in aquaculture, and molecular epidemiological studies of fish diseases. His groundbreaking work in anti-viral gene expression studies of carps has opened new frontiers in aquatic disease control. Additionally, he has contributed significantly to the development of medicines for ornamental fish diseases, innovative immunostimulants, and bioactive compounds derived from algae and plant derivatives. His pioneering research on enclosure culture in inland open waters has transformed sustainable fisheries management, providing innovative solutions for fish conservation and productivity.

Accolades and Recognition 🏆

Dr. Das’s illustrious career has been adorned with numerous prestigious awards. He received the Jawaharlal Nehru Award for outstanding postgraduate research from ICAR, followed by the Lal Bahadur Shastri Young Scientist Award (1999–2000). His excellence in fisheries science earned him the Dr. M.S. Swaminathan Award (2011) and the Krushi Ratna Award (2016). His remarkable contributions were further acknowledged with the Eminent Zoologist of the Year Award (2017), the Ganesh Chandra Vidyarthi Award (2018), and the Best Annual Report Award (2019). In recognition of his institutional leadership, ICAR-CIFRI received the Sardar Patel Outstanding ICAR Institution Award (2020) under his direction. The pinnacle of his accolades includes the Rafi Ahmed Kidwai Award (2020) for outstanding research in agricultural sciences and the Agri-Food Empowering India Award (2021).

Impact and Influence on the Global Scientific Community 🌍

Dr. Das has built strong international collaborations, expanding the reach of Indian fisheries research to the global stage. He has established vital partnerships with WorldFish, FAO, NACA, GIZ, SAARC, BOBP, IUCN, World Bank, and leading universities such as RMIT University, University of Manitoba, University of Waterloo, and University of Aberdeen. His role in policy advisory and scientific development has helped shape sustainable aquaculture practices worldwide. Additionally, his commitment to academic mentorship is reflected in his guidance of 25 Ph.D. scholars, 35 Master’s students, two postdoctoral researchers, and two international scholars. His contribution to fisheries education and scientific discourse is further amplified by 13 MoUs with government departments, commercial enterprises, and research collaborations.

Scientific Contributions and Publications 📚

Dr. Das’s prolific research output stands as a testament to his enduring impact on fisheries science. With over 375 international publications and 8,286 citations, his work has significantly influenced the global scientific community. His extensive research on fish diseases, bioactive compounds, and molecular diagnostics has provided critical insights into improving fish health management and enhancing aquaculture sustainability. His contributions continue to be referenced by researchers, policymakers, and industry leaders worldwide, reinforcing his position as a thought leader in aquatic sciences.

Legacy and Future Contributions 🚀

As a visionary in fisheries science, Dr. Basanta Kumar Das’s contributions extend beyond research and academia. His work has set new benchmarks in disease management, aquaculture sustainability, and molecular epidemiology. His leadership in inland fisheries research will continue to drive innovations in biotechnological advancements for disease prevention, eco-friendly aquaculture techniques, and sustainable fisheries management. With a steadfast commitment to environmental conservation and scientific excellence, his legacy will inspire future generations of researchers to explore the uncharted depths of aquatic sciences and contribute to a more resilient and productive fisheries sector.

Publication

 

  • Effect of Achyranthes aspera on the immunity and survival of Labeo rohita infected with Aeromonas hydrophila
    Authors: YV Rao, BK Das, P Jyotyrmayee, R Chakrabarti
    Year: 2006

 

  • Toxicity of cypermethrin in Labeo rohita fingerlings: biochemical, enzymatic and haematological consequences
    Authors: BK Das, SC Mukherjee
    Year: 2003

 

  • Effect of Allium sativum on the immunity and survival of Labeo rohita infected with Aeromonas hydrophila
    Authors: S Sahu, BK Das, BK Mishra, J Pradhan, N Sarangi
    Year: 2007

 

  • Effect of long term administration of dietary β-glucan on immunity, growth and survival of Labeo rohita fingerlings
    Authors: CK Misra, BK Das, SC Mukherjee, P Pattnaik
    Year: 2006

 

  • Effect of Magnifera indica kernel as a feed additive on immunity and resistance to Aeromonas hydrophila in Labeo rohita fingerlings
    Authors: S Sahu, BK Das, J Pradhan, BC Mohapatra, BK Mishra, N Sarangi
    Year: 2007

 

  • Effect of multiple injections of β-glucan on non-specific immune response and disease resistance in Labeo rohita fingerlings
    Authors: CK Misra, BK Das, SC Mukherjee, P Pattnaik
    Year: 2006

 

  • Spatial distribution of meso and microplastics in the sediments of river Ganga at eastern India
    Authors: DJ Sarkar, SD Sarkar, BK Das, RK Manna, BK Behera, S Samanta
    Year: 2019

 

  • Emergence of tilapia lake virus associated with mortalities of farmed Nile tilapia Oreochromis niloticus (Linnaeus 1758) in India
    Authors: BK Behera, PK Pradhan, TR Swaminathan, N Sood, P Paria, A Das, …
    Year: 2018

 

  • A histopathological study of carp (Labeo rohita) exposed to hexachlorocyclohexane
    Authors: BK Das, SC Mukherjee
    Year: 2000

 

  • A predator–prey interaction model with self and cross-diffusion
    Authors: B Dubey, B Das, J Hussain
    Year: 2001

 

Conclusion

Dr. Basanta Kumar Das’s legacy in fisheries science is marked by groundbreaking research, transformative leadership, and unwavering dedication to advancing aquatic health, sustainable fisheries, and innovative disease management solutions. His scientific endeavors have revolutionized inland aquaculture, bridging the gap between traditional fisheries practices and modern molecular research. Through his mentorship, institutional leadership, and global collaborations, he continues to shape the next generation of fisheries scientists while working toward sustainable and eco-friendly aquaculture solutions. His lifelong commitment to fisheries research ensures that his contributions will have a lasting impact on the global fisheries sector, environmental conservation, and food security.

Bastian Höchst | Onco- Immunology | Best Researcher Award

Published on by Neuroscientists

Dr. Bastian Höchst | Onco- Immunology | Best Researcher Award

Dr. Bastian Höchst,  Institute of Molecular Immunology, MRI, TUM, Germany.

Bastian Höchst is a distinguished molecular immunologist whose career spans groundbreaking research, impactful teaching, and valuable contributions to the scientific community. His academic journey began with a focus on biology and culminated in a doctorate on immune regulation in liver tumors. As a Research Group Leader at the Technical University of Munich, he investigates the complex interplay of immune cells and tissues in acute and chronic inflammation. His pioneering discoveries, such as the mechanisms governing myeloid suppressor cells and immune-regulatory metabolite transfer, have advanced understanding in the field.

Profile

Google Scholar

🌱 Early Academic Pursuits

Bastian Höchst began his academic journey with a passion for understanding the intricate mechanisms of biology. From 1999 to 2005, he pursued his studies in Biology at the University of Bonn and Hamburg, laying the foundation for his future endeavors in molecular immunology. His academic curiosity led him to pursue a doctorate at the Medical School Hannover under the guidance of Prof. Dr. Tim F. Greten. His doctoral research focused on identifying and characterizing myeloid-derived suppressor cells in patients with hepatocellular carcinoma, marking the beginning of his impactful contributions to the field of immunology.

🔬 Professional Endeavors

Currently serving as a Research Group Leader at the Institute of Molecular Immunology, Klinikum rechts der Isar, Technical University of Munich (TUM), Bastian Höchst has dedicated his career to unraveling the complexities of immune regulation. His journey in academia has been marked by significant roles, including his previous tenure as a Research Group Leader at the Institute for Animal Physiology and Immunology, Wissenschaftszentrum Weihenstephan, TUM. Additionally, his postdoctoral fellowship at the Institute of Molecular Medicine and Experimental Immunology at the University of Bonn further honed his expertise in immune mechanisms.

🧪 Contributions and Research Focus

Bastian Höchst’s research delves into immune regulation within acute and chronic inflammatory processes, with a particular focus on tissue-specific mechanisms. He has made groundbreaking discoveries, including elucidating the pathways that govern the generation of myeloid suppressor cells in liver tumors. Furthermore, his innovative work revealed that the intercellular transfer of immune-regulatory metabolites is critical to T-cell effector functions. His research has significantly advanced the understanding of immune responses in disease contexts, bridging gaps in immunological knowledge.

🎓 Teaching and Mentorship

A dedicated educator, Bastian Höchst has been actively involved in teaching since 2010, inspiring students in life sciences programs at TUM. His lectures on topics such as onco-immunology, immune metabolism, and immunotherapy provide invaluable insights to aspiring scientists. Through lab courses on immune cell phenotyping and advanced techniques like spectral flow cytometry, he has empowered students with the skills to explore the complexities of immunology. His teaching contributions extend beyond knowledge dissemination, fostering a generation of critical thinkers and innovators.

📜 Accolades and Recognition

Bastian’s expertise has been recognized through his habilitation and venia legendi for Molecular Immunology, under the mentorship of Prof. Dr. Percy Knolle. His contributions as a scientific reviewer for prestigious journals like Hepatology, Journal of Hepatology, and Frontiers in Immunology further reflect his authority in the field. Additionally, his role in evaluating grant applications for the Deutsche Forschungsgemeinschaft (DFG) underscores his impact on shaping future research initiatives.

🌍 Impact and Influence

Through his research, teaching, and reviews, Bastian Höchst has left an indelible mark on the field of molecular immunology. His work not only uncovers critical mechanisms of immune regulation but also provides pathways for therapeutic advancements in inflammatory and tumor-related conditions. His contributions influence both scientific understanding and practical applications, addressing global challenges in health and disease management.

🌟 Legacy and Future Contributions

Bastian Höchst’s journey is one of passion, discovery, and impact. As he continues to lead groundbreaking research, he sets the stage for a future where immune-based therapies are revolutionized. His legacy lies in his ability to connect fundamental research with real-world applications, inspiring colleagues and mentees alike. With his unwavering commitment to scientific exploration, Bastian Höchst is poised to shape the future of molecular immunology, paving the way for transformative breakthroughs.

Publication

  • A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+ CD25+ Foxp3+ T cells
    Authors: B. Höchst, L.A. Ormandy, M. Ballmaier, F. Lehner, C. Krüger, M.P. Manns, …
    Year: 2008

 

  • Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
    Authors: B. Höchst, T. Voigtlaender, L. Ormandy, J. Gamrekelashvili, F. Zhao, …
    Year: 2009

 

  • Functional classification of memory CD8+ T cells by CX3CR1 expression
    Authors: J.P. Böttcher, M. Beyer, F. Meissner, Z. Abdullah, J. Sander, B. Höchst, …
    Year: 2015

 

  • Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells
    Authors: B. Höchst, J. Gamrekelashvili, M.P. Manns, T.F. Greten, F. Korangy
    Year: 2011

 

  • S100A9 a new marker for monocytic human myeloid‐derived suppressor cells
    Authors: F. Zhao, B. Höchst, A. Duffy, J. Gamrekelashvili, S. Fioravanti, M.P. Manns, …
    Year: 2012

 

  • Regulatory myeloid cells paralyze T cells through cell–cell transfer of the metabolite methylglyoxal
    Authors: T. Baumann, A. Dunkel, C. Schmid, S. Schmitt, M. Hiltensperger, K. Lohr, …
    Year: 2020

 

  • Kupffer cell-derived Tnf triggers cholangiocellular tumorigenesis through JNK due to chronic mitochondrial dysfunction and ROS
    Authors: D. Yuan, S. Huang, E. Berger, L. Liu, N. Gross, F. Heinzmann, M. Ringelhan, …
    Year: 2017

 

  • Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCC
    Authors: T.F. Greten, L.A. Ormandy, A. Fikuart, B. Höchst, S. Henschen, M. Hörning, …
    Year: 2010

 

Conclusion

Bastian Höchst’s career exemplifies dedication to advancing molecular immunology through innovative research, education, and mentorship. His contributions have shaped the understanding of immune responses in disease contexts, offering hope for novel therapeutic approaches. As he continues to lead impactful research and foster new talent, Bastian Höchst remains a visionary in his field, poised to drive future breakthroughs that bridge science and medicine for the benefit of society.

 

Baoying Huang | Pathogen Biology | Best Researcher Award

Published on by Neuroscientists

Baoying Huang | Pathogen Biology | Best Researcher Award

Ms. Baoying Huang,  National Institute for Viral Disease Control and Prevention, China.

Dr. Baoying Huang, a distinguished professor at the Biotech Center for Viral Disease Emergency, China CDC, has over two decades of experience in combating viral diseases. Her expertise lies in vaccine and antiviral drug development for emerging and re-emerging infectious diseases, including COVID-19, monkeypox, and other human coronaviruses.

 

profile

Scopus

🎓 Education Experience

2008.09–2011.07: Doctor of Medicine, Pathogen Biology,Biotech Center for Viral Disease Emergency, China CDC.2005.09–2008.07: Master of Biology, Pathogen Biology,Biotech Center for Viral Disease Emergency, China CDC. 2001.09–2005.07: Bachelor of Biology,
Life Science Department, Nan Hua University, China.

👩‍🔬 Professional Experience

2020.07–Present:  Professor, China CD ,Focus: Vaccine and antiviral drug R&D for SARS-CoV-2 and poxvirus diseases, including COVID-19 and monkeypox. Key Role: Participated in COVID-19 Emergency Projects for SARS-CoV-2 variant monitoring in China.2015.07–2020.07:  Associate Professor, China CDC. Focus: Vaccine and antiviral drug R&D for emerging infectious diseases like influenza and coronaviruses (SARS-CoV, MERS-CoV).2015.04–2015.06:  Assistant Professor, China CDC. Global Health Support Program: Worked in Sierra Leone to establish Ebola lab systems, improving public health infrastructure.2011.07–2015.07: Assistant Professor, China CDC. Focus: Pathogenic molecular mechanisms of influenza viruses, pseudo-virus applications, and gene-engineered vaccines. 2005.09–2011.07:  Graduate Researcher, IVDC, China CDC. Specialization: Developing universal influenza vaccines for cross-protection against various strains.

🔬 Research Focus

Baoying Huang’s work is dedicated to:Vaccine Development: COVID-19 vaccines (BBIBP-CorV, mRNA vaccines) and pan-orthopoxvirus solutions.Emerging Diseases: Countermeasures for SARS-CoV-2, monkeypox, and other viral threats.Diagnostics: Whole-genome sequencing and real-time PCR for virus detection and monitoring.Therapeutics: Screening novel antivirals targeting viruses like SARS-CoV-2 and monkeypox.Key achievements include:Leading the development of Sinopharm COVID-19 vaccine, later approved by WHO for Emergency Use Listing.Establishing monitoring systems for SARS-CoV-2 variants and assessing their impact on public health measures. Advancing monkeypox vaccine research and identifying promising antiviral compounds against orthopoxviruses.

📚 Publications

  • Title: Molecular architecture of monkeypox mature virus
    • Authors: Hong, Y., Huang, B., Zhang, J., Tan, W., Li, S.
    • Year: 2024

 

  • Title: Vaccinia virus Tiantan strain blocks host antiviral innate immunity and programmed cell death by disrupting gene expression
    • Authors: Wu, C., Zhang, Z., Li, Z., Deng, Y., Tan, W.
    • Year: 2024

 

  • Title: A clinically used anti-human papilloma virus agent (3-hydroxyphthalic anhydride-modified bovine β-lactoglobulin) has a potential for topical application to prevent sexual transmission of monkeypox virus
    • Authors: Sha, Y., Huang, B., Hua, C., Tan, W., Jiang, S.
    • Year: 2024

 

  • Title: Development of a multiplex real-time PCR assay for the simultaneous detection of mpox virus and orthopoxvirus infections
    • Authors: Fan, Z., Xie, Y., Huang, B., Tan, W., Guo, F.
    • Year: 2024

 

  • Title: Accurate determination of the whole genome sequencing and open reading frames composition of non-replicating Tiantan strain of vaccinia virus based on novel long read sequencing platform
    • Authors: Zhang, Z., Wu, C., Li, H., Huang, B., Tan, W.
    • Year: 2024

 

  • Title: Characterization of whole genomes from recently emerging Mpox cases in several regions of China, 2023
    • Authors: Wu, C., Cui, L., Pan, Y., Wang, Q., Tan, W.
    • Year: 2024

 

  • Title: Intranasal immunization with single-dose vaccine based on recombinant influenza virus H1N1 expressing the extracellular domain of respiratory syncytial virus G protein induces robust immunity and protection in mice
    • Authors: Han, R., Wang, D., Wang, T., Huang, B., Tan, W.
    • Year: 2024

 

  • Title: Rapid identification of full-length genome and tracing variations of monkeypox virus in clinical specimens based on mNGS and amplicon sequencing
    • Authors: Wu, C., A, R., Ye, S., Lu, J., Tan, W.
    • Year: 2024

 

  • Title: Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population
    • Authors: Li, M., Guo, Y., Deng, Y., Gao, G.F., Liu, J.
    • Year: 2024

 

  • Title: Identification of the VP37 pocket of monkeypox virus as a promising target for pan-orthopoxvirus inhibitors through virtual screening and antiviral assays
    • Authors: Huo, S., Wu, L., Huang, B., Xu, Z., Tan, W.
    • Year: 2024

 

Conclusion

Dr. Huang’s career exemplifies unwavering dedication to improving public health through innovation in vaccine development, antiviral research, and diagnostic technologies. Her contributions to tackling global health challenges, such as the COVID-19 pandemic and monkeypox outbreaks, have significantly impacted infectious disease prevention and control worldwide. As viruses continue to evolve, her pioneering work remains a cornerstone in safeguarding global health.